Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI
about
Clopidogrel: the data, the experience, and the controversies.Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases.Significance of clopidogrel resistance related to the stent-assisted angioplasty in patients with atherosclerotic cerebrovascular disease.Cangrelor for the treatment of arterial thrombosis: pharmacokinetics/pharmacodynamics and clinical data.Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score.Recent developments in clopidogrel pharmacology and their relation to clinical outcomes.Cangrelor: a novel P2Y12 receptor antagonist.Platelet P2Y12 receptor inhibition by thienopyridines: status and future.Cangrelor: a review on its mechanism of action and clinical development.Emerging drugs for acute myocardial infarction.Update on the clinical development of cangrelor.Review: Antiplatelet drugs: what comes next?Ticagrelor: from discovery to Phase III clinical trial.Antiplatelet therapy and vascular disease: an update.Emerging antiplatelet agents, differential pharmacology, and clinical utility.P2Y12 receptor: platelet thrombus formation and medical interventions.Modern antiplatelet agents in coronary artery disease.Cangrelor: a review on pharmacology and clinical trial development.Cangrelor: review of the drug and the CHAMPION programme (including PHOENIX).A Safety Evaluation of Cangrelor in Patients Undergoing PCI.Overcoming limitations of current antiplatelet drugs: a concerted effort for more profitable strategies of intervention.CangrelorHORIZONS trial: a step forward for primary percutaneous coronary intervention.
P2860
Q30573045-82D3E675-02EF-412F-9601-5E66D548E556Q33685876-329FE14C-5BC7-4F93-99DC-469DA46441E3Q35176063-9E18A608-10F1-4384-B10D-9EEDFC6C328CQ35569714-F0136065-3DF6-4EF3-9003-0F83AD37A2EEQ37156100-DC9DC7A8-2C2D-4637-A05C-8869B7A5F5B0Q37540088-2F6B5DFD-3511-4C91-8339-8D995C00E7B2Q37551923-6F62C847-9519-4C31-B0FF-773086AB6C10Q37579228-C33F1F48-298E-49BB-AA2A-C9E686617F38Q37611039-C7B10F99-8AC8-4F65-B668-FD4291BF394DQ37670190-AA53A66E-2770-498F-91D9-32B373165E07Q37776511-75191E98-9873-4406-BE61-4CDF9222F257Q37809630-802F947D-7CB9-47C0-A603-F209487326FDQ37818206-BB79C748-7F29-4031-81EA-7414C9A60208Q37838100-60BCC045-B210-40CD-8700-5F15CD66A74AQ37979178-5536735C-F313-4427-B4F4-596DFC8ADBC2Q38051192-238C8DC2-6529-49CD-9263-98786C6940E5Q38063289-2108E637-BF79-4F5C-9D3A-DF4A8656C2BDQ38153779-85D7E724-5329-4A71-9FDC-DE7851B53B51Q38216215-B298D91A-325F-4E7E-95E6-8C3EEC146BFFQ38672923-FF04A090-297D-4B81-9186-4FB9E7E6CBC5Q39635786-79723BF1-63F2-47C6-B7F7-E0CE07E9F0CBQ42385435-350DBF28-EEA3-4A9E-AFDD-69F99C422992Q46125254-A0C16AA7-7244-40A7-B9B8-F0E30C3BE2CB
P2860
Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Preliminary experience with in ...... yocardial Infarction (STEP-AMI
@nl
type
label
Preliminary experience with in ...... yocardial Infarction (STEP-AMI
@nl
prefLabel
Preliminary experience with in ...... yocardial Infarction (STEP-AMI
@nl
P2093
P50
P1476
Preliminary experience with in ...... (STEP-AMI) angiographic trial
@en
P2093
Adam B Greenbaum
C Michael Gibson
Jill E Stankowski
Michel R Le May
Steven Borzak
W Douglas Weaver
P356
10.1016/J.AHJ.2007.06.001
P407
P577
2007-10-01T00:00:00Z